Sedation and guided education for depression
Part of Mental health clinical trials.
This study tests whether using sedation (medicine to help you relax) along with guided education can help treat depression. It may provide a new treatment option for people with moderate to severe depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with major depressive disorder that is at least moderate in severity.
- You are able to read, understand, and sign a consent form.
- You are not pregnant or breastfeeding.
- You do not have certain substance use disorders (e.g., alcohol, drugs).
- You do not take opioid painkillers or benzodiazepines (like Xanax, Valium) on a daily basis.
- You have no history of psychosis, schizophrenia, or schizoaffective disorder.
- Your body mass index (BMI) is not above 35, and you do not have untreated moderate or severe sleep apnea.
- You do not have any gastrointestinal condition that increases your risk of choking or breathing in food/liquid (aspiration).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a group education program (psychoeducation) for people with moderate to severe major depression. It’s designed to help you learn skills to manage your depression alongside medication.
This study tests how a medication called memantine affects memory and mood in people with major depression who are not currently taking antidepressants. It involves MRI scans and may help find new ways to treat depression.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
This study tests a remote education program (tele-education) for people with moderate depression who recently started an antidepressant. The program helps you learn skills to manage your mood, and you can take part from home.
This Phase 2 trial tests whether an NMDA-targeted treatment can improve symptoms of major depressive disorder (MDD). You may be able to join if your depression diagnosis and symptom score fit, and you meet several safety and study-following requirements.
This study tests whether a combination of cognitive training (brain exercises) and a medication (guanfacine or sertraline) can improve thinking skills in people with depression. It involves MRI scans and computer tasks to understand how your brain responds.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.